277 related articles for article (PubMed ID: 33989290)
1. Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease.
Donley DW; Realing M; Gigley JP; Fox JH
PLoS One; 2021; 16(5):e0250606. PubMed ID: 33989290
[TBL] [Abstract][Full Text] [Related]
2. Huntingtons Disease Mice Infected with Toxoplasma gondii Demonstrate Early Kynurenine Pathway Activation, Altered CD8+ T-Cell Responses, and Premature Mortality.
Donley DW; Olson AR; Raisbeck MF; Fox JH; Gigley JP
PLoS One; 2016; 11(9):e0162404. PubMed ID: 27611938
[TBL] [Abstract][Full Text] [Related]
3. The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain.
Mazarei G; Budac DP; Lu G; Lee H; Möller T; Leavitt BR
Exp Neurol; 2013 Nov; 249():144-8. PubMed ID: 23994717
[TBL] [Abstract][Full Text] [Related]
4. Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington's disease pathology.
Savage JC; St-Pierre MK; Carrier M; El Hajj H; Novak SW; Sanchez MG; Cicchetti F; Tremblay MÈ
J Neuroinflammation; 2020 Apr; 17(1):98. PubMed ID: 32241286
[TBL] [Abstract][Full Text] [Related]
5. Nuclear translocation of STAT5 initiates iron overload in huntington's disease by up-regulating IRP1 expression.
Niu L; Zhou Y; Wang J; Zeng W
Metab Brain Dis; 2024 Apr; 39(4):559-567. PubMed ID: 38261161
[TBL] [Abstract][Full Text] [Related]
6. Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin.
Connolly C; Magnusson-Lind A; Lu G; Wagner PK; Southwell AL; Hayden MR; Björkqvist M; Leavitt BR
Neuroscience; 2016 Jun; 325():74-88. PubMed ID: 27033979
[TBL] [Abstract][Full Text] [Related]
7. Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model.
Lu Z; Marks E; Chen J; Moline J; Barrows L; Raisbeck M; Volitakis I; Cherny RA; Chopra V; Bush AI; Hersch S; Fox JH
Neurobiol Dis; 2014 Nov; 71():34-42. PubMed ID: 25014023
[TBL] [Abstract][Full Text] [Related]
8. Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease.
Berggren KL; Chen J; Fox J; Miller J; Dodds L; Dugas B; Vargas L; Lothian A; McAllum E; Volitakis I; Roberts B; Bush AI; Fox JH
Redox Biol; 2015; 4():363-74. PubMed ID: 25703232
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease.
Jin J; Albertz J; Guo Z; Peng Q; Rudow G; Troncoso JC; Ross CA; Duan W
J Neurochem; 2013 May; 125(3):410-9. PubMed ID: 23373812
[TBL] [Abstract][Full Text] [Related]
10. Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice.
Petkau TL; Hill A; Connolly C; Lu G; Wagner P; Kosior N; Blanco J; Leavitt BR
Hum Mol Genet; 2019 May; 28(10):1661-1670. PubMed ID: 30624705
[TBL] [Abstract][Full Text] [Related]
11. Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington's disease.
Sathyasaikumar KV; Stachowski EK; Amori L; Guidetti P; Muchowski PJ; Schwarcz R
J Neurochem; 2010 Jun; 113(6):1416-25. PubMed ID: 20236387
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease.
Mazarei G; Budac DP; Lu G; Adomat H; Tomlinson Guns ES; Möller T; Leavitt BR
J Neurochem; 2013 Dec; 127(6):852-67. PubMed ID: 23786539
[TBL] [Abstract][Full Text] [Related]
13. IKKβ slows Huntington's disease progression in R6/1 mice.
Ochaba J; Fote G; Kachemov M; Thein S; Yeung SY; Lau AL; Hernandez S; Lim RG; Casale M; Neel MJ; Monuki ES; Reidling J; Housman DE; Thompson LM; Steffan JS
Proc Natl Acad Sci U S A; 2019 May; 116(22):10952-10961. PubMed ID: 31088970
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease.
Boros FA; Klivényi P; Toldi J; Vécsei L
Expert Opin Ther Targets; 2019 Jan; 23(1):39-51. PubMed ID: 30449219
[TBL] [Abstract][Full Text] [Related]
15. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.
Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S
Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156
[TBL] [Abstract][Full Text] [Related]
16. TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration.
Creus-Muncunill J; Haure-Mirande JV; Mattei D; Bons J; Ramirez AV; Hamilton BW; Corwin C; Chowdhury S; Schilling B; Ellerby LM; Ehrlich ME
J Neuroinflammation; 2024 Mar; 21(1):66. PubMed ID: 38459557
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease.
Mazarei G; Leavitt BR
J Huntingtons Dis; 2015; 4(2):109-18. PubMed ID: 26397892
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice.
Corona AW; Norden DM; Skendelas JP; Huang Y; O'Connor JC; Lawson M; Dantzer R; Kelley KW; Godbout JP
Brain Behav Immun; 2013 Jul; 31():134-42. PubMed ID: 22926082
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment.
Giorgini F; Möller T; Kwan W; Zwilling D; Wacker JL; Hong S; Tsai LC; Cheah CS; Schwarcz R; Guidetti P; Muchowski PJ
J Biol Chem; 2008 Mar; 283(12):7390-400. PubMed ID: 18079112
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of copper ion mediated Huntington's disease progression.
Fox JH; Kama JA; Lieberman G; Chopra R; Dorsey K; Chopra V; Volitakis I; Cherny RA; Bush AI; Hersch S
PLoS One; 2007 Mar; 2(3):e334. PubMed ID: 17396163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]